A Phase 3, Randomized, Double-Blind, Placebo-Controlled,

Project: Research project

Description

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) in Combination with nab-Paclitaxel Plus Gemcitabine
StatusActive
Effective start/end date4/28/165/31/21

Funding

  • HALOZYME, INC.

Fingerprint

gemcitabine
Hyaluronoglucosaminidase
Multicenter Studies
Placebos
130-nm albumin-bound paclitaxel